Cover Image
市場調查報告書

單純皰疹病毒感染疾病 (HSV感染疾病) :開發中產品分析

Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

出版商 Global Markets Direct 商品編碼 362371
出版日期 內容資訊 英文 177 Pages
訂單完成後即時交付
價格
Back to Top
單純皰疹病毒感染疾病 (HSV感染疾病) :開發中產品分析 Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016
出版日期: 2016年06月08日 內容資訊: 英文 177 Pages
簡介

本報告提供單純皰疹病毒感染疾病 (HSV感染疾病) 治療藥的開發情形相關調查,提供您開發中產品概要,各臨床實驗階段的產品概要,主要企業及藥物簡介,開發中產品的最新趨勢,及最新消息/新聞稿等資訊。

簡介

單純皰疹病毒感染疾病 (HSV感染疾病)的概要

治療藥的開發

單純皰疹病毒感染疾病 (HSV感染疾病) :企業開發中的治療藥

單純皰疹病毒感染疾病 (HSV感染疾病) :大學/機關研究中的治療藥

單純皰疹病毒感染疾病 (HSV感染疾病) :開發中產品概況

單純皰疹病毒感染疾病 (HSV感染疾病) :企業開發中的產品

單純皰疹病毒感染疾病 (HSV感染疾病) :大學/機關研究中的產品

單純皰疹病毒感染疾病 (HSV感染疾病)的治療藥的開發企業

單純皰疹病毒感染疾病 (HSV感染疾病) :治療藥的評估

藥物簡介

單純皰疹病毒感染疾病 (HSV感染疾病) :最近的開發平台趨勢

單純皰疹病毒感染疾病 (HSV感染疾病) :暫停中的計劃

單純皰疹病毒感染疾病 (HSV感染疾病) :開發中止的產品

單純皰疹病毒感染疾病 (HSV感染疾病) :產品開發的里程碑

附錄

目錄
Product Code: GMDHC8166IDB

Summary

Global Markets Direct's, 'Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016', provides an overview of the Herpes Simplex Virus (HSV) Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Herpes Simplex Virus (HSV) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Herpes Simplex Virus (HSV) Infections and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Herpes Simplex Virus (HSV) Infections
  • The report reviews pipeline therapeutics for Herpes Simplex Virus (HSV) Infections by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved Herpes Simplex Virus (HSV) Infections therapeutics and enlists all their major and minor projects
  • The report assesses Herpes Simplex Virus (HSV) Infections therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news related to pipeline therapeutics for Herpes Simplex Virus (HSV) Infections

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Herpes Simplex Virus (HSV) Infections
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Herpes Simplex Virus (HSV) Infections pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
  • Introduction
  • Herpes Simplex Virus (HSV) Infections Overview
  • Therapeutics Development
  • Herpes Simplex Virus (HSV) Infections - Therapeutics under Development by Companies
  • Herpes Simplex Virus (HSV) Infections - Therapeutics under Investigation by Universities/Institutes
  • Herpes Simplex Virus (HSV) Infections - Pipeline Products Glance
  • Herpes Simplex Virus (HSV) Infections - Products under Development by Companies
  • Herpes Simplex Virus (HSV) Infections - Products under Investigation by Universities/Institutes
  • Herpes Simplex Virus (HSV) Infections - Companies Involved in Therapeutics Development
  • Herpes Simplex Virus (HSV) Infections - Therapeutics Assessment
  • Drug Profiles
  • Herpes Simplex Virus (HSV) Infections - Recent Pipeline Updates
  • Herpes Simplex Virus (HSV) Infections - Dormant Projects
  • Herpes Simplex Virus (HSV) Infections - Discontinued Products
  • Herpes Simplex Virus (HSV) Infections - Product Development Milestones
  • Appendix

List of Tables

  • Number of Products under Development for Herpes Simplex Virus (HSV) Infections, H1 2016
  • Number of Products under Development for Herpes Simplex Virus (HSV) Infections - Comparative Analysis, H1 2016
  • Number of Products under Development by Companies, H1 2016
  • Number of Products under Development by Companies, H1 2016 (Contd..1)
  • Number of Products under Development by Companies, H1 2016 (Contd..2)
  • Number of Products under Investigation by Universities/Institutes, H1 2016
  • Comparative Analysis by Late Stage Development, H1 2016
  • Comparative Analysis by Clinical Stage Development, H1 2016
  • Comparative Analysis by Early Stage Development, H1 2016
  • Products under Development by Companies, H1 2016
  • Products under Development by Companies, H1 2016 (Contd..1)
  • Products under Development by Companies, H1 2016 (Contd..2)
  • Products under Investigation by Universities/Institutes, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Adamis Pharmaceuticals Corporation, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Admedus Ltd, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by AiCuris GmbH & Co. KG, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Almirall, S.A., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Astellas Pharma Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Beech Tree Labs, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Beijing Minhai Biotechnology Co., Ltd, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by BioApex, s.r.o., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by CEL-SCI Corporation, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Editas Medicine, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Epiphany Biosciences, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Foamix Pharmaceuticals Ltd., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Genocea Biosciences, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by GenVec, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Immune Design Corp., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Immunovaccine, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by JN-International Medical Corporation, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Microbiotix, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Mymetics Corporation, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by NanoBio Corporation, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by NanoViricides, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Onxeo SA, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by PaxVax, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Profectus BioSciences, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by ReceptoPharm, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Redbiotec AG, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Sanofi, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Sanofi Pasteur SA, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Savoy Pharmaceuticals, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Shulov Innovative Science Ltd., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Spider Biotech, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Starpharma Holdings Limited, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by TGV-Laboratories, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Tomegavax, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by United BioPharma, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Vaccibody AS, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Vaxart, Inc., H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Vical Incorporated, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by Vironova AB, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Pipeline by ViroStatics srl, H1 2016
  • Assessment by Monotherapy Products, H1 2016
  • Assessment by Combination Products, H1 2016
  • Number of Products by Stage and Target, H1 2016
  • Number of Products by Stage and Mechanism of Action, H1 2016
  • Number of Products by Stage and Route of Administration, H1 2016
  • Number of Products by Stage and Molecule Type, H1 2016
  • Herpes Simplex Virus (HSV) Infections Therapeutics - Recent Pipeline Updates, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Dormant Projects, H1 2016
  • Herpes Simplex Virus (HSV) Infections - Dormant Projects (Contd..1), H1 2016
  • Herpes Simplex Virus (HSV) Infections - Dormant Projects (Contd..2), H1 2016
  • Herpes Simplex Virus (HSV) Infections - Dormant Projects (Contd..3), H1 2016
  • Herpes Simplex Virus (HSV) Infections - Dormant Projects (Contd..4), H1 2016
  • Herpes Simplex Virus (HSV) Infections - Discontinued Products, H1 2016

List of Figures

  • Number of Products under Development for Herpes Simplex Virus (HSV) Infections, H1 2016
  • Number of Products under Development for Herpes Simplex Virus (HSV) Infections - Comparative Analysis, H1 2016
  • Number of Products under Development by Companies, H1 2016
  • Number of Products under Investigation by Universities/Institutes, H1 2016
  • Comparative Analysis by Late Stage Development, H1 2016
  • Comparative Analysis by Clinical Stage Development, H1 2016
  • Comparative Analysis by Early Stage Products, H1 2016
  • Assessment by Monotherapy Products, H1 2016
  • Number of Products by Top 10 Targets, H1 2016
  • Number of Products by Stage and Top 10 Targets, H1 2016
  • Number of Products by Top 10 Mechanism of Actions, H1 2016
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016
  • Number of Products by Top 10 Routes of Administration, H1 2016
  • Number of Products by Stage and Top 10 Routes of Administration, H1 2016
  • Number of Products by Top 10 Molecule Types, H1 2016
  • Number of Products by Stage and Top 10 Molecule Types, H1 2016
Back to Top